Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Malignant Melanoma

  Free Subscription


12.04.2021

2 Ann Surg Oncol
1 Anticancer Res
2 BMC Cancer
1 BMC Ophthalmol
2 Br J Cancer
1 Br J Dermatol
2 Cancer
1 Eur J Dermatol
1 Int J Cancer
3 J Am Acad Dermatol
1 J Cell Physiol
2 J Invest Dermatol
3 N Engl J Med
1 Oncogene
1 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Surg Oncol

  1. SHANNON AB, Wood C, Straker RJ 3rd, Miura JT, et al
    Age and Mitogenicity are Important Predictors of Sentinel Lymph Node Metastasis in T1a Melanoma.
    Ann Surg Oncol. 2021 Apr 8. pii: 10.1245/s10434-021-09929.
    PubMed        

  2. AHMADI O, Mathy JA
    ASO Author Reflections: Diagnosis of Melanoma Using Shave Biopsy has Minimal Impact on Tumor Staging and Treatment and Does Not Influence Patient Outcomes.
    Ann Surg Oncol. 2021 Apr 1. pii: 10.1245/s10434-021-09935.
    PubMed        


    Anticancer Res

  3. BOCZAR D, Bagaria SP, Spaulding AC, Huayllani MT, et al
    Treatment Contraindications Based on Comorbidity Status in Patients With Melanoma in the United States.
    Anticancer Res. 2021;41:2067-2070.
    PubMed         Abstract available


    BMC Cancer

  4. WANG L, Chen F, Liu R, Shi L, et al
    Gene expression and immune infiltration in melanoma patients with different mutation burden.
    BMC Cancer. 2021;21:379.
    PubMed         Abstract available

  5. COROIU A, Moran C, Davine JA, Brophy K, et al
    Patient-identified early clinical warning signs of nodular melanoma: a qualitative study.
    BMC Cancer. 2021;21:371.
    PubMed         Abstract available


    BMC Ophthalmol

  6. MIYAMOTO R, Nakashizuka H, Tanaka K, Wakatsuki Y, et al
    Bilateral multiple serous retinal detachments after treatment with nivolumab: a case report.
    BMC Ophthalmol. 2020;20:221.
    PubMed         Abstract available


    Br J Cancer

  7. AMERATUNGA M, Brana I, Bono P, Postel-Vinay S, et al
    First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours.
    Br J Cancer. 2020;123:1730-1736.
    PubMed         Abstract available

  8. DHOMEN N, Mundra PA, Marais R
    Sunglasses to hide behind may also prevent melanoma of the eyes.
    Br J Cancer. 2021 Apr 6. pii: 10.1038/s41416-021-01343.
    PubMed         Abstract available


    Br J Dermatol

  9. KITTLER H
    Total body photography for secondary prevention of melanoma.
    Br J Dermatol. 2021 Apr 6. doi: 10.1111/bjd.20058.
    PubMed        


    Cancer

  10. BROMAN KK, Hughes T, Dossett L, Sun J, et al
    Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy trial II (MSLT-2).
    Cancer. 2021 Apr 7. doi: 10.1002/cncr.33483.
    PubMed         Abstract available

  11. GERSHENWALD JE
    Active surveillance of patients who have melanoma with a positive sentinel node in an era of effective adjuvant therapy: Early lessons learned ... and still learning.
    Cancer. 2021 Apr 7. doi: 10.1002/cncr.33484.
    PubMed        


    Eur J Dermatol

  12. SCARD C, Nguyen JM, Varey E, Moustaghfir I, et al
    Cardiac adverse events associated with anti-PD-1 therapy in patients treated for advanced melanoma: relevance of dosing troponin T levels.
    Eur J Dermatol. 2021 Apr 2. pii: ejd.2021.4009. doi: 10.1684/ejd.2021.4009.
    PubMed         Abstract available


    Int J Cancer

  13. SUN Q, Novak D, Huser L, Poelchen J, et al
    FOXD1 Promotes Dedifferentiation and Targeted Therapy Resistance in Melanoma by Regulating the Expression of CTGF.
    Int J Cancer. 2021 Apr 9. doi: 10.1002/ijc.33591.
    PubMed         Abstract available


    J Am Acad Dermatol

  14. BARRIOS DM, Do MH, Phillips GS, Postow MA, et al
    Immune checkpoint inhibitors to treat cutaneous malignancies.
    J Am Acad Dermatol. 2020;83:1239-1253.
    PubMed         Abstract available

  15. HEYMANN WR
    Melanoma Healthcare and Outcome Disparities: You Can Never Be Too Rich or Too Thin.
    J Am Acad Dermatol. 2021 Apr 3. pii: S0190-9622(21)00679.
    PubMed        

  16. BAYERS S, Orseth M, Prasad S, Hynan LS, et al
    Community-based melanoma screening: A pilot study for the development of an educational curriculum for nonphysician providers.
    J Am Acad Dermatol. 2021 Mar 29. pii: S0190-9622(21)00362.
    PubMed        


    J Cell Physiol

  17. ROSTAMI N, Nikkhoo A, Khazaei-Poul Y, Farhadi S, et al
    Coinhibition of S1PR1 and GP130 by siRNA-loaded alginate-conjugated trimethyl chitosan nanoparticles robustly blocks development of cancer cells.
    J Cell Physiol. 2020;235:9702-9717.
    PubMed         Abstract available


    J Invest Dermatol

  18. MUNIZ TP, Sorotsky H, Kanjanapan Y, Rose AAN, et al
    Genomic Landscape of Malignant Peripheral Nerve Sheath Tumor-like Melanoma.
    J Invest Dermatol. 2021 Apr 5. pii: S0022-202X(21)01132.
    PubMed         Abstract available

  19. HARBERS FN, Thier B, Stupia S, Zhu S, et al
    Melanoma differentiation trajectories determine sensitivity towards pre-existing CD8(+) tumor-infiltrating lymphocytes.
    J Invest Dermatol. 2021 Mar 30. pii: S0022-202X(21)01124.
    PubMed         Abstract available


    N Engl J Med

  20. GROSSMAN D, Sweeney C, Doherty JA
    The Rapid Rise in Cutaneous Melanoma Diagnoses.
    N Engl J Med. 2021;384:e54.
    PubMed        

  21. GOLDSMITH SM
    The Rapid Rise in Cutaneous Melanoma Diagnoses.
    N Engl J Med. 2021;384:e54.
    PubMed        

  22. ADAMSON AS, Mazer BL, Welch HG
    The Rapid Rise in Cutaneous Melanoma Diagnoses. Reply.
    N Engl J Med. 2021;384:e54.
    PubMed        


    Oncogene

  23. KAKUMANI PK, Guitart T, Houle F, Harvey LM, et al
    CSDE1 attenuates microRNA-mediated silencing of PMEPA1 in melanoma.
    Oncogene. 2021 Apr 8. pii: 10.1038/s41388-021-01767.
    PubMed         Abstract available


    PLoS One

  24. LORUSSO PM, Sekulic A, Sosman JA, Liang WS, et al
    Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial.
    PLoS One. 2021;16:e0248097.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  25. FALAHAT R, Berglund A, Putney RM, Perez-Villarroel P, et al
    Epigenetic reprogramming of tumor cell-intrinsic STING function sculpts antigenicity and T cell recognition of melanoma.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: